KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HCA Healthcare (HCA) Long-Term Debt Repayments (2016 - 2025)

HCA Healthcare (HCA) has disclosed Long-Term Debt Repayments for 16 consecutive years, with $1.6 billion as the latest value for Q4 2025.

  • On a quarterly basis, Long-Term Debt Repayments rose 2329.69% to $1.6 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $5.9 billion, a 152.35% increase, with the full-year FY2025 number at $7.4 billion, up 206.6% from a year prior.
  • Long-Term Debt Repayments was $1.6 billion for Q4 2025 at HCA Healthcare, up from $174.0 million in the prior quarter.
  • In the past five years, Long-Term Debt Repayments ranged from a high of $3.9 billion in Q1 2025 to a low of $47.0 million in Q1 2021.
  • A 5-year average of $793.3 million and a median of $129.0 million in 2022 define the central range for Long-Term Debt Repayments.
  • Biggest YoY gain for Long-Term Debt Repayments was 9856.76% in 2021; the steepest drop was 98.59% in 2021.
  • HCA Healthcare's Long-Term Debt Repayments stood at $82.0 million in 2021, then tumbled by 31.71% to $56.0 million in 2022, then surged by 289.29% to $218.0 million in 2023, then crashed by 70.64% to $64.0 million in 2024, then skyrocketed by 2329.69% to $1.6 billion in 2025.
  • Per Business Quant, the three most recent readings for HCA's Long-Term Debt Repayments are $1.6 billion (Q4 2025), $174.0 million (Q3 2025), and $291.0 million (Q2 2025).